Home > Insider Trading > Filing (0000899243-22-001245)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1098972	Agenus Inc	AGEN	Biological Products, (No Disgnostic Substances) (2836)	061562417

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1845281	J Steven O'day	C/O Agenus Inc. 3 Forbes Road Lexington MA 02421	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-01-04	100,000	$0.00	100,000	No	4	M	Direct
Common Stock	Disposition	2022-01-06	38,679	$3.06	61,321	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2022-01-04	100,000	$0.00	100,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Restricted stock units convert into common stock on a one-for-one basis.
Represents sales of shares, as a consequence of the vesting of restricted stock units, to cover Federal, state and local tax withholding requirements related to the vesting. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.055 to $3.065. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On January 4, 2021, the reporting person was granted 100,000 restricted stock units that fully vested on January 4, 2022.